bes has been researched along with Hemorrhage in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djambas Khayat, C; Knaub, S; Kruzhkova, I; Lohade, SD; Peyvandi, F; Solomon, C; Zekavat, OR | 1 |
| Castaman, G; Escobar, M; Leebeek, FWG; Miesbach, W; Özen, G; Peyvandi, F; Susen, S; Tiede, A; Wang, M; Wang, S; Wang, Y; Zhang, J; Zülfikar, B | 1 |
| Abraham, A; Belletrutti, MJ; Belyanskaya, L; Carcao, M; Carvalho, M; Chambost, H; Chan, AKC; Dubey, L; Ducore, J; Gattens, M; Gresele, P; Gruel, Y; Guillet, B; Jansen, M; Jiménez-Yuste, V; Kitanovski, L; Klukowska, A; Knaub, S; Lohade, S; Mancuso, ME; Mathias, M; Neufeld, EJ; Oldenburg, J; Pollio, B; Sigaud, M; Vilchevska, K; Walter, O; Wu, JKM | 1 |
1 trial(s) available for bes and Hemorrhage
| Article | Year |
|---|---|
Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.
Topics: Adult; Hemorrhage; Humans; Recombinant Proteins; von Willebrand Disease, Type 3; von Willebrand Diseases; von Willebrand Factor | 2023 |
2 other study(ies) available for bes and Hemorrhage
| Article | Year |
|---|---|
Analysis of fibrinogen concentrate pharmacokinetics and dosing for bleeds and surgery in adults, adolescents, and children with congenital afibrinogenaemia and hypofibrinogenaemia.
Topics: Adolescent; Adult; Afibrinogenemia; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibrinogen; Hemorrhage; Hemostatics; Humans; Prospective Studies; Rare Diseases; Young Adult | 2022 |
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Topics: Factor VIII; Hemophilia A; Hemorrhage; Humans; Treatment Outcome | 2023 |